Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia W Durbin

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Health Physics|October 14, 2008
Lauriston S. Taylor Lecture: the quest for therapeutic actinide chelatorsPatricia W Durbin
Radiation Protection Dosimetry|September 4, 2007
The NCRP wound model: development and applicationRaymond A Guilmette, Patricia W Durbin, Richard E Toohey, et al.
Journal of Medicinal Chemistry|August 23, 2002
Synthesis and initial evaluation for in vivo chelation of Pu(IV) of a mixed octadentate spermine-based ligand containing 4-carbamoyl-3-hydroxy-1-methyl-2(1H)-pyridinone and 6-carbamoyl-1-hydroxy-2(1H)-pyridinoneJide Xu, Patricia W Durbin, Birgitta Kullgren, et al.
Health Physics|August 12, 2010
Biomimetic actinide chelators: an update on the preclinical development of the orally active hydroxypyridonate decorporation agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO)Rebecca J Abergel, Patricia W Durbin, Birgitta Kullgren, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Health Physics|October 14, 2008
Lauriston S. Taylor Lecture: the quest for therapeutic actinide chelatorsPatricia W Durbin
Radiation Protection Dosimetry|September 4, 2007
The NCRP wound model: development and applicationRaymond A Guilmette, Patricia W Durbin, Richard E Toohey, et al.
Journal of Medicinal Chemistry|August 23, 2002
Synthesis and initial evaluation for in vivo chelation of Pu(IV) of a mixed octadentate spermine-based ligand containing 4-carbamoyl-3-hydroxy-1-methyl-2(1H)-pyridinone and 6-carbamoyl-1-hydroxy-2(1H)-pyridinoneJide Xu, Patricia W Durbin, Birgitta Kullgren, et al.
Health Physics|August 12, 2010
Biomimetic actinide chelators: an update on the preclinical development of the orally active hydroxypyridonate decorporation agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO)Rebecca J Abergel, Patricia W Durbin, Birgitta Kullgren, et al.
Pageof 1